Alcon announces acquisition of Tear Film Innovations
Alcon, a Novartis division, announced it has acquired Tear Film Innovations, a privately-held company and manufacturer of the iLux® Device, an innovative therapeutic device used to treat Meibomian Gland Dysfunction, a leading cause of dry eye. December 19, 2018